ClinicalTrials.gg
CompletedNCT03719378Updated Mar 16, 2021Results posted

Traditional vs Oral Fluid Management in Total Knee Arthroplasty

An interventional study of Pre Operative Oral Fluids in Arthroplasty, Replacement, Knee, sponsored by Colorado Joint Replacement. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-03-16.

Sponsored by Colorado Joint Replacement · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 1 year 10 months after the study started (first participant enrolled Oct 2015, registered Sep 2017).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Purpose: Evidence-based guidelines on optimal perioperative fluid management have not been established in patients undergoing orthopaedic surgery. Recent randomized trials in major abdominal surgery suggest that large amounts of IV fluid may increase morbidity and hospital stay. This study will investigate the effects of two regimens of intraoperative fluid management ("traditional" vs. "oral") with physiologic and patient function as primary outcome measures after surgery.

Read the detailed description

Evidence-based guidelines on optimal perioperative fluid management have not been established in patients undergoing orthopaedic surgery. Typical intraoperative and post-operative fluid management has been arbitrary without evidence based guidelines established following total joint replacement. The investigators have observed many patients post-operatively with side effects such as fluid overload leading to medical complications requiring either prolonged hospitalization or readmission. Additionally, this overload may lead to wound healing complications secondary to fluid shifts which may be devastating in this patient population. Recent randomized trials in major abdominal surgery suggest that large amounts of IV fluid may increase morbidity and hospital stay. Additionally, this increase fluid may be detrimental in patients with anastomosis leading to failure and/or complications in this patient population. The investigators have defined to specific groups of interest to study in this patient population with regards to fluid management. The first group is the "traditional" IV fluid group where the anesthesiologist gives an unspecific amount of fluid intraoperatively and post-operatively the patient gets a set amount of fluid based on "protocol" on the orthopaedic floor (i.e. 75 cc/hour until good oral intake). This is the protocol utilized by most orthopaedic practices throughout the United States. The second group is defined as patients who are given a specific protocol preoperatively to optimize hydration, followed by limited fluids intraoperatively based on physiologic parameters. This study will investigate the effects of two regimens of intraoperative fluid management ("traditional" vs. "oral") with

02

Conditions studied

  • Arthroplasty, Replacement, Knee

Keywords

  • Fluid Management
03

In context

Lead sponsor

Colorado Joint Replacement is the lead sponsor of 10 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients between the ages of 18-75 years old undergoing a primary total knee arthroplasty for a diagnosis of degenerative osteoarthritis who do not meet the exclusion criteria listed below

Exclusion criteria

Exclusion Criteria:

  • Volume-dependent cardiac conditions:
  • Aortic stenosis
  • Pulmonary valve stenosis
  • Subaortic stenosis
  • Severe Aortic Insufficiency
  • Chronic systolic heart failure
  • Eisenmeinger Syndrome
  • Severe pulmonary HTN
  • Chronic or paroxysmal dysrhythmias
  • Pre-operative electrolyte abnormalities
  • Abnormalities of the HPA (hypothalamic-pituitary axis)
  • Stage 3 Chronic Kidney Disease (or worse)
  • Patients taking angiotensin receptor blockers (ARB)
  • Patients with uncontrolled diabetes mellitus (patient with of 7+ or on insulin)
  • Patients whose is > 35 38 or \< 19
  • Current use of long acting narcotic medication or 3 or more months of daily short acting narcotic medication
  • Patients at risk for electrolyte abnormalities, dehydration or intra-operative hypotension. (patients taking angiotensin receptor blockers, ACE inhibitors (48 hours prior to surgery) and Diuretics)
  • Patients with severe, untreated or uncontrolled GERD.
  • Patients that cannot receive spinal anesthesia (e.g. patient with back fusions)
  • Pre-Operative Anemia
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
150 participants (actual)

Study arms

  • No intervention
    Traditional Fluid

    * NPO Clears and Food after midnight. * 2 Liters of lactated ringers administered by anesthesia intraoperatively. * Postoperatively - 2 Liters of Crystalloid while in PACU and Inpatient Room for a Total of 4 Liters of Crystalloid within 24 hours. (Patient will receive 500 milliliters while in PACU and 1500 milliliters while in their Inpatient Room, for a total of 2 Liters). * Normal diet postoperatively.

  • Experimental
    Oral Fluid

    * Pre Operative Oral Fluids (Patients encouraged to drink a minimum of 60 ounces of clear liquid per day for the 3 days prior to procedure.) * NPO Food/Milk: none beginning 8 hours prior to procedure time. * Pre Operative Oral Fluids (Patients are asked to drink 10 ounces of clear liquid 4 hours prior to their scheduled procedure time.) * Preoperative holding area, IV is started in the patient with Lactated Ringers IV fluid at a rate of 75ml/hr. IV fluids will be stopped and hep-locked in the PACU when the patient is taking PO fluid; the total amount of IV fluids is not to exceed 500ml total. * PO fluid protocol: a minimum of 60 ounces of liquid per day for 3 days.

    Other: Pre Operative Oral Fluids

Interventions

  • OtherPre Operative Oral Fluids

    Patients will be self hydrating prior to their total knee replacement.

06

What researchers measure

Primary outcomes

  1. Body Weight

    Patient Weight will be monitored

    Time frame: Change is patients weight from baseline at pre op to two weeks post op.

Secondary outcomes

  1. Knee Range of Motion

    Measurements will be done with a standard goniometer (Measurements below are shown as the difference from their pre operative base line measurement to the time points below)

    Time frame: Post Op Day 1, 2 Weeks and 6 Weeks Post Op

  2. Leg Anthropometric (Girth) Measurements

    measurements will be performed at 5 \& 10 cm suprapatellar, midpatella, and 10 cm infrapatellar with the use of a standard tape measure. measurements below show the difference from their pre operative base line measurement to the timepoints below.

    Time frame: Post op Day 1, 2 weeks and 6 weeks Post Op

  3. Number of Participants With Requiring Transfusions

    Post Operative/Intra Operative Transfusions

    Time frame: intra operative, Post Op Day #1 or #2

  4. Number of Participants With Off Wound Complications Post Operative

    incidence of wound infection and wound drainage will be assessed and recorded

    Time frame: Up to 6 weeks Post OP

  5. Number of Participants With Thromboembolic Disease

    The incidence of thromboembolic events will be recorded.

    Time frame: Post Opeartive until the 6 week follow up appointment

  6. Quadriceps Strength Measure With a Handheld Dynamometer

    The strength testing will be calculated using a handheld dynamometer

    Time frame: Post Op day 1, 2 Week and 6 Week Post OP

  7. Time up and GO

    timed up and go (TUG)

    Time frame: preoperative appointment and once again at their 2 and 6 weeks postoperatively

  8. 30 Second STS Test

    30 second sit-to-stand tests

    Time frame: preoperative appointment and once again at their 2 and 6 weeks postoperatively

  9. Length of the Hospitalization

    Length of time the patient is Hospitalized after their total knee replacement.

    Time frame: Daily up to 2 days while hospitalized

  10. Number of Patients Re-admitted Post TKA

    Number of patients re-admitted post TKA

    Time frame: up to 6 weeks post op

  11. Postoperative Pain Assessment Using Visual Analog Scale

    Pain will be assessed using a pain Visual Analog scale(VAS), the scale is from 1 to 10, the higher the score the worse the pain.

    Time frame: Every 4 hours, averaged daily, reported at Post op day 1 and 2 (while in the hospital), weeks 1, 2, 3, and 4 (3 times a day)

  12. PONV (Post-operative Nausea and Vomiting)

    patients will be asked about Nausea: None, Mild, Moderate or Severe

    Time frame: Daily up to 2 days while hospitalized

  13. Veterans Rand -12

    Patient Reported Outcomes- Veterans Rand(VR-12), there is an algorithm to calculate this score, not a specific range. The higher the number the more positive the output. The score has two components a mental score (MCS) and Physical Score (PCS). Higher values represent a better outcome. MCS Scale 35.089613 to 46.341715 PCS Scale 14.957554 to 63.235672

    Time frame: 2 week and 6 week follow up appointments

  14. Patient Reported Outcomes - Knee Injury and Osteoarthritis Outcome Score (KOOS)

    Knee injury and Osteoarthritis Outcome Score (KOOS), the scale is 0 to 100, 100 being the best score possible.

    Time frame: pre-operatively as well as at their 2 week and 6 week follow up appointments

  15. Patient Reported Outcomes - Knee Society Score(KSS)

    Knee Society Score(KSS), the total scores range from 0 - 200, 200 being the best.

    Time frame: pre-operatively as well as at their 2 week and 6 week follow up appointments

  16. Total IV Fluids Received

    Total amount of IV fluids that the patients received while in the hospital

    Time frame: Duration of IV intervention, up to 2 days

  17. Bioimpedence

    body composition before and after surgery to measure swelling. Lower numbers represent more swelling.

    Time frame: pre-op visit, Post Op Day #1 as well as their 2 week and 6 week visit

Other outcomes

  1. Number of Participants With Adverse Events

    episodes such as symptomatic hypotension (light-headedness, syncope), emesis, the need the IV fluid boluses, and other hospital and post-discharge events will be recorded

    Time frame: While in hospital until the 6 week follow up appointment

  2. Blood Pressure

    Blood Pressure (Diastolic/ Systolic)

    Time frame: Daily up to 2 days while hospitalized

  3. Total Number of Patients That Received Any Pressor Drugs

    total amount of any pressor drugs given intraoperatively (e.g. Ephedrine and Phenylephrine)

    Time frame: Up to Day 1 Post op

07

Results

Posted Mar 16, 2021

Participant flow

Participant flow — Overall Study
MilestoneTraditional FluidOral Fluid
Started7575
Completed6565
Not completed1010

Outcome measures

PrimaryBody Weight

Patient Weight will be monitored

Time frame:
Change is patients weight from baseline at pre op to two weeks post op.
Reported as:
Mean · pounds
Body Weight
poundsTraditional FluidOral Fluid
Body Weight-1.9 ± 4.4-1.6 ± 4.4
SecondaryKnee Range of Motion

Measurements will be done with a standard goniometer (Measurements below are shown as the difference from their pre operative base line measurement to the time points below)

Time frame:
Post Op Day 1, 2 Weeks and 6 Weeks Post Op
Reported as:
Mean · degrees
Knee Range of Motion
degreesTraditional FluidOral Fluid
Post Op Day 1-30.5 ± 18.5-26.7 ± 16
2 Weeks Post Op-27.9 ± 17.5-25.5 ± 16.5
6 Weeks Post OP-7.7 ± 17-4.8 ± 13.2
SecondaryLeg Anthropometric (Girth) Measurements

measurements will be performed at 5 \& 10 cm suprapatellar, midpatella, and 10 cm infrapatellar with the use of a standard tape measure. measurements below show the difference from their pre operative base line measurement to the timepoints below.

Time frame:
Post op Day 1, 2 weeks and 6 weeks Post Op
Reported as:
Mean · inches
Leg Anthropometric (Girth) Measurements
inchesTraditional FluidOral Fluid
(10 cm suprapatellar) Post Op day 12.5 ± 3.02.1 ± 3.1
(10 cm suprapatellar) 2 weeks post op0.9 ± 3.01.6 ± 4.0
(10 cm suprapatellar) 6 weeks post op0.00 ± 2.60.00 ± 3.3
(5 cm suprapatellar) Post Op day 14.1 ± 2.44.0 ± 2.6
(5 cm suprapatellar) 2 weeks post op2.0 ± 2.32.8 ± 2.6
(5 cm suprapatellar) 6 weeks post op0.9 ± 1.91.0 ± 2.2
(Midpatellar) Post Op day 14.6 ± 2.24.1 ± 2.6
(Midpatellar) 2 weeks post op2.2 ± 2.33.0 ± 2.0
(Midpatellar) 6 weeks post op1.3 ± 1.61.3 ± 2.0
(10 cm inferior patella) Post Op day 12.7 ± 2.71.5 ± 4.6
(10 cm inferior patella) 2 weeks post op0.8 ± 2.10.9 ± 2.3
(10 cm inferior patella) 6 weeks post op-0.2 ± 1.30.1 ± 1.5
SecondaryNumber of Participants With Requiring Transfusions

Post Operative/Intra Operative Transfusions

Time frame:
intra operative, Post Op Day #1 or #2
Reported as:
Count of participants · Participants
Number of Participants With Requiring Transfusions
ParticipantsTraditional FluidOral Fluid
Number of Participants With Requiring Transfusions01
SecondaryNumber of Participants With Off Wound Complications Post Operative

incidence of wound infection and wound drainage will be assessed and recorded

Time frame:
Up to 6 weeks Post OP
Reported as:
Count of participants · Participants
Number of Participants With Off Wound Complications Post Operative
ParticipantsTraditional FluidOral Fluid
Number of Participants With Off Wound Complications Post Operative00
SecondaryNumber of Participants With Thromboembolic Disease

The incidence of thromboembolic events will be recorded.

Time frame:
Post Opeartive until the 6 week follow up appointment
Reported as:
Count of participants · Participants
Number of Participants With Thromboembolic Disease
ParticipantsTraditional FluidOral Fluid
Number of Participants With Thromboembolic Disease10
SecondaryQuadriceps Strength Measure With a Handheld Dynamometer

The strength testing will be calculated using a handheld dynamometer

Time frame:
Post Op day 1, 2 Week and 6 Week Post OP
Reported as:
Mean · KG
Quadriceps Strength Measure With a Handheld Dynamometer
KGTraditional FluidOral Fluid
Change from Preop to Post Op Day1-10.4 ± 7.6-11.2 ± 7.1
Change from Preop to 2 weeks post op-9.0 ± 6.5-9.6 ± 7.2
Change from Preop to 6 weeks post op-3.2 ± 5.8-3.8 ± 6.5
SecondaryTime up and GO

timed up and go (TUG)

Time frame:
preoperative appointment and once again at their 2 and 6 weeks postoperatively
Reported as:
Mean · Seconds
Time up and GO
SecondsTraditional FluidOral Fluid
Change from Preop to 2 weeks Post op4.4 ± 4.83.3 ± 3.7
Change from Preop to 6 weeks Post op-4.7 ± 3.5-4.0 ± 3.9
Secondary30 Second STS Test

30 second sit-to-stand tests

Time frame:
preoperative appointment and once again at their 2 and 6 weeks postoperatively
Reported as:
Mean · sit-to-stand events
30 Second STS Test
sit-to-stand eventsTraditional FluidOral Fluid
Change from Preop to 2 weeks Post op-5.3 ± 4.0-4.4 ± 4.6
Change from Preop to 6 weeks Post op-0.4 ± 4.10.3 ± 3.0
SecondaryLength of the Hospitalization

Length of time the patient is Hospitalized after their total knee replacement.

Time frame:
Daily up to 2 days while hospitalized
Reported as:
Count of participants · Participants
Length of the Hospitalization
ParticipantsTraditional FluidOral Fluid
1 Day5663
2 Days92
SecondaryNumber of Patients Re-admitted Post TKA

Number of patients re-admitted post TKA

Time frame:
up to 6 weeks post op
Reported as:
Count of participants · Participants
Number of Patients Re-admitted Post TKA
ParticipantsTraditional FluidOral Fluid
Number of Patients Re-admitted Post TKA10
SecondaryPostoperative Pain Assessment Using Visual Analog Scale

Pain will be assessed using a pain Visual Analog scale(VAS), the scale is from 1 to 10, the higher the score the worse the pain.

Time frame:
Every 4 hours, averaged daily, reported at Post op day 1 and 2 (while in the hospital), weeks 1, 2, 3, and 4 (3 times a day)
Reported as:
Mean · units on a scale
Postoperative Pain Assessment Using Visual Analog Scale
units on a scaleTraditional FluidOral Fluid
Average Post Op Day 12.6 ± 1.42.3 ± 1.4
Average Post Op Day 24.4 ± 1.54.5 ± 1.6
Average Week 14.3 ± 1.64.1 ± 1.6
Average Week 23.6 ± 1.83.4 ± 1.5
Average Week 33.0 ± 1.73.2 ± 1.7
Average Week 42.7 ± 1.62.6 ± 1.4
SecondaryPONV (Post-operative Nausea and Vomiting)

patients will be asked about Nausea: None, Mild, Moderate or Severe

Time frame:
Daily up to 2 days while hospitalized
Reported as:
Count of participants · Participants
PONV (Post-operative Nausea and Vomiting)
ParticipantsTraditional FluidOral Fluid
None5146
Mild912
Moderat33
Severe24
SecondaryVeterans Rand -12

Patient Reported Outcomes- Veterans Rand(VR-12), there is an algorithm to calculate this score, not a specific range. The higher the number the more positive the output. The score has two components a mental score (MCS) and Physical Score (PCS). Higher values represent a better outcome. MCS Scale 35.089613 to 46.341715 PCS Scale 14.957554 to 63.235672

Time frame:
2 week and 6 week follow up appointments
Reported as:
Mean · score on a scale
Veterans Rand -12
score on a scaleTraditional FluidOral Fluid
Change from Preop - 2 Weeks Post Op Mental Score-4.7 ± 12.2-1.2 ± 10.4
Change from Preop - 2 Weeks PostOp Physical Score-8.3 ± 10-4.5 ± 11.2
Change from Pre op - 6 Weeks Post Op Mental Score-2.5 ± 11.5-3.2 ± 11.4
Change from Preop - 6 Weeks PostOp Physical Score-0.5 ± 10.62.2 ± 12.2
SecondaryPatient Reported Outcomes - Knee Injury and Osteoarthritis Outcome Score (KOOS)

Knee injury and Osteoarthritis Outcome Score (KOOS), the scale is 0 to 100, 100 being the best score possible.

Time frame:
pre-operatively as well as at their 2 week and 6 week follow up appointments
Reported as:
Mean · score on a scale
Patient Reported Outcomes - Knee Injury and Osteoarthritis Outcome Score (KOOS)
score on a scaleTraditional FluidOral Fluid
Change is score from pre op to 2 weeks-1.6 ± 16.23.1 ± 13.8
Change is score from pre op to 6 weeks9.4 ± 14.512.3 ± 14.1
SecondaryPatient Reported Outcomes - Knee Society Score(KSS)

Knee Society Score(KSS), the total scores range from 0 - 200, 200 being the best.

Time frame:
pre-operatively as well as at their 2 week and 6 week follow up appointments
Reported as:
Mean · score on a scale
Patient Reported Outcomes - Knee Society Score(KSS)
score on a scaleTraditional FluidOral Fluid
Change from Preop to 2 weeks Post op-14.6 ± 39.9-0.2 ± 36.2
Change from pre op to 6 weeks31.9 ± 36.340.5 ± 35.4
SecondaryTotal IV Fluids Received

Total amount of IV fluids that the patients received while in the hospital

Time frame:
Duration of IV intervention, up to 2 days
Reported as:
Median · ML
Total IV Fluids Received
MLTraditional FluidOral Fluid
Total IV Fluids Received3895 (1500 to 5322)350 (177 to 1466)
SecondaryBioimpedence

body composition before and after surgery to measure swelling. Lower numbers represent more swelling.

Time frame:
pre-op visit, Post Op Day #1 as well as their 2 week and 6 week visit
Reported as:
Mean · ohms
Bioimpedence
ohmsTraditional FluidOral Fluid
Change from Preop to Post Op Day1-17.8 ± 30.34.2 ± 29.7
Change from Preop to 2 weeks post op-41.4 ± 34.2-38.5 ± 45.7
Change from Preop to 6 weeks post op-30.9 ± 25.6-31.0 ± 31.4
Other pre-specifiedNumber of Participants With Adverse Events

episodes such as symptomatic hypotension (light-headedness, syncope), emesis, the need the IV fluid boluses, and other hospital and post-discharge events will be recorded

Time frame:
While in hospital until the 6 week follow up appointment
Reported as:
Count of participants · Participants
Number of Participants With Adverse Events
ParticipantsTraditional FluidOral Fluid
Number of Participants With Adverse Events32
Other pre-specifiedBlood Pressure

Blood Pressure (Diastolic/ Systolic)

Time frame:
Daily up to 2 days while hospitalized
Reported as:
Mean · Change in mmHg
Blood Pressure
Change in mmHgTraditional FluidOral Fluid
Change in mmHg Pre Op to Recovery Room (Systolic)21.5 ± 15.926.0 ± 16.7
Change in mmHg Pre Op to Recovery Room (Diastolic)18.4 ± 12.217.2 ± 11.9
Change in mmHg Pre Op to Arrival on 4th floor (Systolic)10.6 ± 12.819.4 ± 13.5
Change in mmHg Pre Op to Arrival on 4th floor (Diastolic)10.5 ± 10.39.3 ± 10.8
Change in mmHg Pre Op to 08:00 on floor (Systolic)17.0 ± 12.923.4 ± 13.3
Change in mmHg Pre Op to 08:00 on floor (Diastolic)16.5 ± 9.316.0 ± 9.6
Change in mmHg Pre Op to 16:00 on floor (Systolic)20.9 ± 14.025.8 ± 13.8
Change in mmHg Pre Op to 16:00 on floor (Diastolic)16.3 ± 11.218.7 ± 11.8
Change in mmHg Pre Op to 24:00 on floor (Systolic)12.5 ± 14.712.5 ± 12.9
Change in mmHg Pre Op to 24:00 on floor (Diastolic)14.6 ± 9.911.1 ± 10.2
Other pre-specifiedTotal Number of Patients That Received Any Pressor Drugs

total amount of any pressor drugs given intraoperatively (e.g. Ephedrine and Phenylephrine)

Time frame:
Up to Day 1 Post op
Reported as:
Count of participants · Participants
Total Number of Patients That Received Any Pressor Drugs
ParticipantsTraditional FluidOral Fluid
Yes2322
No4243

Adverse events

Collected over 6 Weeks Post Operatively. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Traditional Fluid0/65 (0%)1/65 (1.5%)0/65 (0%)
Oral Fluid0/65 (0%)0/65 (0%)0/65 (0%)
Most frequent serious events
Most frequent serious events
EventTraditional FluidOral Fluid
acute pulmonary embolismRespiratory, thoracic and mediastinal disorders1/650/65

Baseline characteristics

Age, Continuous
Age, Continuous(Years)Traditional FluidOral FluidTotal
Mean61.2 ± 7.560.9 ± 6.861 ± 7.2
Sex: Female, Male
Sex: Female, Male(Participants)Traditional FluidOral FluidTotal
Female444286
Male313364
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Traditional FluidOral FluidTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(participants)Traditional FluidOral FluidTotal
United States7575150
BMI
BMI(kg/m^2 (BMI))Traditional FluidOral FluidTotal
Mean28.5 ± 4.928.1 ± 4.228.3 ± 4.6
08

Study locations

1 site
  • Colorado Joint Replacement
    Denver, Colorado 80210, United States
09

References and documents

Publications

  • Marjanovic G, Villain C, Juettner E, zur Hausen A, Hoeppner J, Hopt UT, Drognitz O, Obermaier R. Impact of different crystalloid volume regimes on intestinal anastomotic stability. Ann Surg. 2009 Feb;249(2):181-5. doi: 10.1097/SLA.0b013e31818b73dc. PubMed 19212167 ↗
  • Marjanovic G, Villain C, Timme S, zur Hausen A, Hoeppner J, Makowiec F, Holzner P, Hopt UT, Obermaier R. Colloid vs. crystalloid infusions in gastrointestinal surgery and their different impact on the healing of intestinal anastomoses. Int J Colorectal Dis. 2010 Apr;25(4):491-8. doi: 10.1007/s00384-009-0854-4. Epub 2009 Nov 27. PubMed 19943164 ↗
  • Kulemann B, Timme S, Seifert G, Holzner PA, Glatz T, Sick O, Chikhladze S, Bronsert P, Hoeppner J, Werner M, Hopt UT, Marjanovic G. Intraoperative crystalloid overload leads to substantial inflammatory infiltration of intestinal anastomoses-a histomorphological analysis. Surgery. 2013 Sep;154(3):596-603. doi: 10.1016/j.surg.2013.04.010. Epub 2013 Jul 19. PubMed 23876362 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2015 to primary completion in Sep 2018, 34 months.

Results were first posted in Mar 2021, 2 years 6 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 6, 2017
First posted
Oct 25, 2018
StartActual
Oct 13, 2015
Primary completionActual
Sep 10, 2018
CompletionActual
Sep 10, 2018
Results first posted
Mar 16, 2021
Last update
Mar 16, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 16, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03719378
Lead sponsor
Colorado Joint Replacement
Responsible party
Jason Jennings (Principal Investigator, Colorado Joint Replacement) — Principal investigator
First posted
Oct 25, 2018
Start date
Oct 13, 2015
Primary completion
Sep 10, 2018
Completion
Sep 10, 2018
Results posted
Mar 16, 2021
Last update
Mar 16, 2021

Study contacts

Jason Jennings, MD
principal investigator · Colorado Joint Replacement

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion